LOGIN
Dabigatran is an inferior thromboembolism prophylactic treatment compared to enoxaparin
May 2013
Dabigatran is an inferior thromboembolism prophylactic treatment compared to enoxaparin
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:N/A
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery
J Arthroplasty. 2009 Jan;24(1):1-9. Epub 2008 Apr 14Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
1896 patients scheduled to undergo total knee arthroplasty were randomized to one of three thromboembolism prophylaxis treatments to determine the best prophylaxis option. Patients either received an oral 220 mg dose of dabigatran once daily, an oral 150 mg dose of dabigatran once daily, or a 30 mg injection of enoxaparin twice daily. The results from this study indicated that both treatments of d...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.